article thumbnail

Bayer launches digital AI platform for radiology specialists

pharmaphorum

Bayer has stepped up the digital capabilities of its radiology business with the launch of artificial intelligence-based apps for X-ray, MRI and CT imaging. ” The post Bayer launches digital AI platform for radiology specialists appeared first on. The business generated sales of €1.8 billion (approximately $1.9

Radiology 111
article thumbnail

Data science pathway prepares radiology residents for machine learning

Scienmag

Credit: Radiological Society of North America OAK BROOK, Ill.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Bayer inks deal with Blackford Analysis to develop radiology AI platform

Pharma Times

Agreement will aim to develop a platform to support radiologists' decision-making

Radiology 112
article thumbnail

UTMB and HDT Bio receive US funding for vaccine development

Pharmaceutical Technology

in a project agreement from the US government for developing self-amplifying RNA (saRNA) vaccine technology against advanced and emergent viral threats. Development of vaccines to Phase I trials under the five-year $59m prototype project comprises additional $28.4m in milestone payments.

article thumbnail

Bayer and Blackford Analysis Announce AI Platform Agreement in Radiology

BioTech 365

Bayer and Blackford Analysis Announce AI Platform Agreement in Radiology Bayer and Blackford Analysis Announce AI Platform Agreement in Radiology Bayer and Blackford Analysis have entered into a development and license agreement to establish an artificial intelligence (AI) platform for … Continue reading →

article thumbnail

Distinguishing real from fake in the age of synthetic images

Medical Xpress

Amid headlines about artificial intelligence's implications for everything from education to the future of work itself, Abhinav Jha, an assistant professor of biomedical engineering at the McKelvey School of Engineering and of radiology at the School of Medicine, both at Washington University in St.

Radiology 127
article thumbnail

Ginkgo Bioworks to discover and develop novel vaccine adjuvants 

Drug Discovery World

A five-year contract totalling up to $31 million including programme options has been awarded to Ginkgo Bioworks to discover and develop next-generation vaccine adjuvants. The post Ginkgo Bioworks to discover and develop novel vaccine adjuvants appeared first on Drug Discovery World (DDW).